Statin use and outcomes of oncological treatment for castration-resistant prostate cancer

Statin use and outcomes of oncological treatment for castration-resistant prostate cancer

Abstract To compare the effect of statin use in relation to castration-resistant prostate cancer (CRPC) treatment, we assessed the risk of ADT-treated PCa-patients to initiate CRPC treatment by statin use and the outcomes of CRPC treatment by statin use. Our study cohort consisted of 1169 men who pa...

Full description

Bibliographic Details
Main Authors: A. I. Peltomaa, K. Talala, K. Taari, T. L. J. Tammela, A. Auvinen, T. J. Murtola
Format: Article
Language:English
Published: Nature Portfolio 2023-11-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-45958-8

Similar Items

Similar Items